Listing Highlights
Co-Located with Medical Clinic
Shares premises with a multi-physician medical clinic, creating a structural referral pipeline and consistent, predictable patient volume that is not dependent on external marketing.
Improving Normalized Earnings
FY2025 normalized EBITDA of approximately $253,000 represents the strongest annual result in the review period, with a positive year-over-year trajectory from the FY2024/FY2025 blended figure of approximately $230,000.
Lean Operating Model
Monday to Friday plus limited Saturday hours. Owner involvement is minimal, demonstrating the pharmacy’s ability to generate earnings without demanding full-time operator commitment.
Major Development Corridor
Located within a Vancouver municipal area undergoing significant residential densification. Growing catchment population represents a clear organic growth opportunity for an incoming owner-operator.
Ten-Year Renewal Option
Current lease expires October 31, 2026, with a ten-year renewal option available. Continuity of premises is negotiable prior to closing, providing long-term operational security.
Share Sale Structure
Offered as a share sale at $1,450,000 — business only. Inventory of approximately $65,000 at cost is settled separately at closing, offering potential tax advantages for qualifying purchasers.
About This Opportunity
This pharmacy has operated continuously for over a decade within the same premises, benefiting from a co-location arrangement with a multi-physician medical clinic. The structural proximity to prescribing physicians creates a reliable referral pipeline that is not dependent on marketing or walk-in traffic — a meaningful differentiator in a competitive urban market.
The business runs on a lean schedule — weekday hours and limited Saturdays — with minimal owner involvement in day-to-day operations. This model demonstrates the pharmacy’s capacity to generate normalized earnings without the time commitment typical of independently operated community pharmacies. FY2025 normalized EBITDA of approximately $253,000 is the strongest result recorded in the review period.
The property is situated within a Vancouver municipal corridor designated for significant residential densification. Population growth in the immediate catchment area represents a clear organic growth opportunity for an incoming owner. The current lease expires October 2026, with a ten-year renewal option available for negotiation prior to closing.
How to Access Full Details
Express Your Interest
Contact us using the inquiry form below or by email. All enquiries are held in strict confidence.
Sign the NDA
We send a straightforward non-disclosure agreement. Most buyers complete it within the hour.
Receive the CIM
Get the full Confidential Information Memorandum including financials within 24 hours of NDA execution.
Meet the Owner
Arrange a site visit and meet the selling pharmacist directly to conduct your due diligence.
Financial Details
Revenue, normalized EBITDA, and asking price are available to qualified buyers after completing our simple NDA process. Most buyers receive the full package within 24 hours.
Annual Revenue
🔒 NDA Required
Normalized EBITDA
🔒 NDA Required
Asking Price
🔒 Contact Us
Inquire About This Listing
All inquiries are confidential. We respond within one business day.
Your information is kept strictly confidential and is never shared without your consent.